Trials / Sponsors / Azura Ophthalmics
Azura Ophthalmics
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | A Phase 3 Study to Evaluate AZR-MD-001 in Patients with Abnormal Meibomian Gland Function and Dry Eye Disease Dry Eye Disease | Phase 3 | 2024-05-28 |
| Completed | Safety, Tolerability and Pharmacodynamics of AZR-MD-001 in Contact Lens Discomfort (CLD) Contact Lens Discomfort | Phase 2 | 2022-11-10 |
| Completed | Evaluation of AZR-MD-001 in Patients With Meibomian Gland Dysfunction (MGD) Meibomian Gland Dysfunction | Phase 2 | 2020-07-17 |
| Completed | Methods to Enhance AZR-MD-001 for Meibomian Gland Dysfunction (MGD) Meibomian Gland Dysfunction | Phase 2 / Phase 3 | 2020-07-14 |
| Completed | An Evaluation of AZR-MD-001 as Treatment for Meibomian Gland Dysfunction (MGD) or Contact Lens Discomfort (CLD Meibomian Gland Dysfunction (MGD), Contact Lens Discomfort (CLD) | Phase 2 | 2019-10-04 |
| Completed | A Multicenter Study Evaluating AZR-MD-001 in Patients With Meibomian Gland Dysfunction and Evaporative Dry Eye Meibomian Gland Dysfunction, Dry Eye | Phase 2 | 2018-09-10 |